Top Markets
#1 The Black Bull The Black Bull +25.10%
#2 EXOD EXOD +22.08%
#3 Unit Plasma Unit Plasma +20.68%
#4 Plasma Plasma +20.42%
#5 SSV Network SSV Network +20.42%
#6 Useless Coin Useless Coin +20.34%
#7 XPIN Network XPIN Network +19.99%
#8 Wrapped XPL Wrapped XPL +19.71%
#9 Ore Ore +19.37%
#10 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +18.14%
Coin of the day
The Black Bull The Black Bull
Settings
Language
ENGLISH
Currency
USD
Theme
Vext Science, Inc. Vext Science, Inc.

Vext Science, Inc.

VEXT
Rank in Stocks #25065
Vext Science, Inc., through its various subsidiaries, operates as a... Vext Science, Inc., through its various subsidiaries, operates as a comprehensive agricultural technology, services, and property management company within the United States cannabis sector. Its operations span the entire product lifecycle, from cultivating and extracting to manufacturing and distributing THC and CBD vape cartridges, concentrates, and edibles. The company also manages retail dispensaries and conducts wholesale distribution of cannabis-derived THC and hemp-derived CBD products, marketed under its Vapen and Pure Touch Botanicals brands. Expanding its edible range, Vext Science offers various THC-infused items under the Vapen Kitchens brand, including Vapen Clear products, chocolate bars, syrups, snacks, candies, and gummies. Incorporated in 2015, the company was formerly known as Vapen MJ Ventures Corporation, adopting its current name, Vext Science, Inc., in November 2019. Its headquarters are located in Phoenix, Arizona.
Share Price
$0.21651138
Last synced: 2026-08-20
Market Cap
$53.63M
Change (1 day)
5.36%
Change (1 year)
15.80%
Country
CA
Trade Vext Science, Inc. (VEXT)

Category

Healthcare
Revenue for Vext Science, Inc. (VEXT)
Revenue in Aug 2026 TTM: 0
According to Vext Science, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Vext Science, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN